• Mon, June 3, 2024

Joseph Pantginis Reiterated (BLRX) at Strong Buy and Held Target at $21 on, Jun 3rd, 2024

Joseph Pantginis of HC Wainwright & Co., Reiterated "BioLineRx Ltd." (BLRX) at Strong Buy and Held Target at $21 on, Jun 3rd, 2024.

Joseph, nor any peers, have made any analyst calls on BLRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍